Karyopharm Therapeutics Inc. (KPTI) Net income 2016–2025
Karyopharm Therapeutics Inc. (KPTI) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$196.0MFY2025 · since FY2016: -$109.6M → -$196.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$196.0M | -156.5% |
| FY2024 | -$76.4M | +46.6% |
| FY2023 | -$143.1M | +13.4% |
| FY2022 | -$165.3M | -33.2% |
| FY2021 | -$124.1M | +36.8% |
| FY2020 | -$196.3M | +1.7% |
| FY2019 | -$199.6M | -11.9% |
| FY2018 | -$178.4M | -38.3% |
| FY2017 | -$129.0M | -17.7% |
| FY2016 | -$109.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice